Literature DB >> 6554235

Modulation of the formation of the human amplification C3 convertase of complement by polycations.

F Maillet, M D Kazatchkine.   

Abstract

Neutralization of the negative charges of heparin by polycations in the fluid phase suppressed the inhibitory effect of heparin on the generation of the C3b-dependent amplification convertase of complement C3b,Bb. Polymeric polycations alone, whether natural or synthetic, prevented formation of the cell-bound amplification convertase and of the fluid-phase interaction of C3b, B and D, in a dose-related fashion in the concentration range of 1 to 2 X 10(-8)M for poly-L-lysine (PLL) 50,000. The inhibitory effect of PLL on formation of the cell-bound convertase was independent of the presence of P. Percent inhibition of C3b,Bb,P and C3b,B,P formation was constant when the convertases were formed with a fixed concentration of PLL and increasing amounts of B; PLL was more effective in preventing convertase formation on cells bearing low numbers of C3b and developed with high doses of B. The decay of the preformed P stabilized convertase was not altered by PLL whether in the presence or absence of H. Thus, polycations in the fluid phase specifically inhibit formation of the amplification C3 convertase by preventing the association between C3b and B, most likely by acting on C3b. The low-affinity interaction between C3b and B is a privileged site for natural or pharmacological modulation of complement by polyelectrolytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6554235      PMCID: PMC1454227     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations.

Authors:  P J Baker; T F Lint; B C McLeod; C L Behrends; H Gewurz
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

2.  Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF).

Authors:  M R Daha; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

3.  Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--I. Effect on fluid phase C1 and on C1 bound to EA or to EAC4.

Authors:  E Raepple; H U Hill; M Loos
Journal:  Immunochemistry       Date:  1976-03

4.  Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).

Authors:  L G Hunsicker; S Ruddy; K F Austen
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

5.  Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement.

Authors:  R Rent; N Ertel; R Eisenstein; H Gewurz
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

6.  Complement activation by interaction of polyanions and polycations.

Authors:  B A Fiedel; R Rent; R Myhrman; H Gewurz
Journal:  Immunology       Date:  1976-02       Impact factor: 7.397

7.  Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

8.  Studies of the inhibition of C56-initiated lysis (reactive lysis). IV. Antagonism of the inhibitory activity c567-INH by poly-L-lysine.

Authors:  B McLeod; P Baker; C Behrends; H Gewurz
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

9.  Control of the amplification convertase of complement by the plasma protein beta1H.

Authors:  J M Weiler; M R Daha; K F Austen; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

10.  Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.

Authors:  D T Fearon; K F Austen
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  1 in total

1.  Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide.

Authors:  Isabelle Bertholon; Christine Vauthier; Denis Labarre
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.